CH215341A - Process for the preparation of Eriodictyol-Cellobiosid. - Google Patents
Process for the preparation of Eriodictyol-Cellobiosid.Info
- Publication number
- CH215341A CH215341A CH215341DA CH215341A CH 215341 A CH215341 A CH 215341A CH 215341D A CH215341D A CH 215341DA CH 215341 A CH215341 A CH 215341A
- Authority
- CH
- Switzerland
- Prior art keywords
- eriodictyol
- split
- parts
- cellobiosid
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von Eriodictyol-cellobiosid. Das Hauptpatent betrifft ein Verfahren zur Herstellung von Eriodictyolglukosid, welches dadurch gekennzeichnet ist, dass man ein Alkalisalz des Briodictyols mit einer Acetohalogenglukose zur Umsetzung bringt und aus dem so erhaltenen Acetyl- glukosid mit Hilfe eines alkalisch reagieren den Mittels die Acetylgruppen abspaltet.
Es wurde weiter gefunden, dass man in analoger Weise Eriodictyolcellobiosid her stellen kann, indem man ein Alkalisalz des Eriodictyols mit einer Heptaacetohalogen- cellobiose zur Umsetzung bringt und aus dem so erhaltenen Heptaacetylcellobiosid mit Hilfe eines alkalisch reagierenden Mittels die Acetylgruppen abspaltet.
Als Heptaaceto- halogencellobiose kommt in erster Linie Heptaacetobromcellobiose in Betracht.
Die neue Verbindung entspricht der For mel
EMI0001.0032
Sie ist wegen ihrer physiologischen Wirk samkeit von Interesse und soll für therapeu tische Zwecke Verwendung finden. Sie bil det ein in Wasser, Methylalkohol und Äthyl- alkohol leicht, in Aceton schwerer, in Äther, Chloroform und Benzol kaum lösliches gel bes Pulver. Sie gibt die Anthocyanidin- reaktion und wird durch Säuren gespalten.
<I>Beispiel:</I> 23 Gewichtsteile Eriodictyol werden un ter Luftabschluss in 300 Volumteilen Aceton und 160 Volumteilen n-Natronlauge gelöst. Hierzu gibt man eine Lösung von 56 Ge- wichtsteilen Heptaacetobromcellobiose in 800 Volumteilen Aceton und lässt das Gemisch über Nacht stehen. Alsdann säuert man mit Essigsäure an und giesst in Essigester. Nach dem Ausschütteln der Essigesterlösung mit Wasser und Bikarbonatlösung wird sie mit Natriumsulfat getrocknet und dann einge dampft.
Der Eindampfrückstand wird in Chloroform gelöst und mit trockenem Äther und Gasolin gefällt.
Dieses Heptaacetylcellobiosid bildet ein gelbliches Pulver ohne scharfen Schmelz punkt.
31 Gewichtsteile Eriodictyol-heptaacetyl- cellobiosid werden in 60 Volumteilen Me thanol gelöst und mittels einer Lösung von 4 Gewichtsteilen Natrium in 80 Volumteilen Methanol in das Natriumsalz verwandelt, das abgesaugt und mittels Essigsäure zerlegt wird. Man dampft ein, löst in Methanol und fällt mit Äther. Das so erhaltene Cellobiosid ist in Wasser sehr leicht löslich und hat keinen Schmelzpunkt, sondern bläht sich beim Erhitzen auf.
Process for the preparation of Eriodictyol-Cellobiosid. The main patent relates to a process for the production of eriodictyol glucoside, which is characterized in that an alkali salt of briodictyol is reacted with an acetohalogenglucose and the acetyl groups are split off from the acetyl glucoside thus obtained with the aid of an alkaline agent.
It has also been found that eriodictyolcellobioside can be prepared in an analogous manner by reacting an alkali salt of eriodictyol with a heptaacetohalogencellobiose and splitting off the acetyl groups from the heptaacetylcellobioside thus obtained with the aid of an alkaline agent.
Heptaacetobromcellobiose comes primarily into consideration as heptaacetohalcellobiose.
The new connection corresponds to the formula
EMI0001.0032
It is of interest because of its physiological efficacy and should be used for therapeutic purposes. It forms a yellow powder that is easily soluble in water, methyl alcohol and ethyl alcohol, more difficult in acetone, and hardly soluble in ether, chloroform and benzene. It gives the anthocyanidin reaction and is split by acids.
<I> Example: </I> 23 parts by weight of Eriodictyol are dissolved in 300 parts by volume of acetone and 160 parts by volume of n-sodium hydroxide solution in the absence of air. A solution of 56 parts by weight of heptaacetobromcellobiose in 800 parts by volume of acetone is added and the mixture is left to stand overnight. It is then acidified with acetic acid and poured into ethyl acetate. After shaking out the ethyl acetate solution with water and bicarbonate solution, it is dried with sodium sulfate and then evaporated.
The evaporation residue is dissolved in chloroform and precipitated with dry ether and gasoline.
This heptaacetyl cellobioside forms a yellowish powder with no sharp melting point.
31 parts by weight of eriodictyol heptaacetyl cellobioside are dissolved in 60 parts by volume of methanol and converted into the sodium salt using a solution of 4 parts by weight of sodium in 80 parts by volume of methanol, which is filtered off with suction and broken down using acetic acid. It is evaporated, dissolved in methanol and precipitated with ether. The cellobioside obtained in this way is very easily soluble in water and has no melting point, but instead puffs up when heated.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE215341X | 1936-12-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH215341A true CH215341A (en) | 1941-06-15 |
Family
ID=96230377
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH210424D CH210424A (en) | 1936-12-24 | 1937-12-20 | Process for the production of eriodictyol glucoside. |
| CH215341D CH215341A (en) | 1936-12-24 | 1937-12-20 | Process for the preparation of Eriodictyol-Cellobiosid. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH210424D CH210424A (en) | 1936-12-24 | 1937-12-20 | Process for the production of eriodictyol glucoside. |
Country Status (1)
| Country | Link |
|---|---|
| CH (2) | CH210424A (en) |
-
1937
- 1937-12-20 CH CH210424D patent/CH210424A/en unknown
- 1937-12-20 CH CH215341D patent/CH215341A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH210424A (en) | 1940-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH215341A (en) | Process for the preparation of Eriodictyol-Cellobiosid. | |
| DE2913856A1 (en) | NEW PROSTAGLAND DERIVATIVES IN THE 6-KETO-PGE TIEF 1 SERIES | |
| DE710966C (en) | Process for the preparation of oxycarboxylic acid esters of the oestrone series | |
| DE728360C (en) | Process for the preparation of a trisubstituted barbituric acid | |
| DE343055C (en) | ||
| CH250806A (en) | Process for the preparation of a new oxyhydrophenanthrene derivative. | |
| DE958844C (en) | Process for the production of ª † -acyl-butyric acids | |
| DE730789C (en) | Process for the preparation of 1-oxyaryloxy-3-alkoxy-2-propanols or -2-propanones | |
| DE957123C (en) | Process for the production of colchicine thioabules | |
| AT157720B (en) | Process for the production of glucosides. | |
| DE692928C (en) | Process for the preparation of C, C-disubstituted thiobarbituric acids | |
| AT151011B (en) | Process for the preparation of glucosides of higher aliphatic alcohols. | |
| DE948059C (en) | Process for the preparation of 4-amino- or 4-acylamino-2-alkoxybenzoic acids | |
| CH327987A (en) | Process for the production of new basic esters | |
| CH250809A (en) | Process for the preparation of a new oxyhydrophenanthrene derivative. | |
| CH212411A (en) | Process for the production of a betaine-like condensation product. | |
| CH181160A (en) | Process for the preparation of a new heterocyclic sulfonic acid. | |
| EP0029527A2 (en) | Prostaglandin derivatives of the 6-keto-PGA1 series, process for their production as well as their use in medicaments and their intermediate products | |
| CH121258A (en) | Process for the preparation of an acyl compound of amino-3-chloro-4-oxybenzene-1-arsic acid. | |
| CH202974A (en) | Process for the preparation of a C, C-disubstituted thiobarbituric acid. | |
| CH302833A (en) | Process for the preparation of a new ester. | |
| CH236223A (en) | Process for the preparation of an inorganic acid ester. | |
| CH225102A (en) | Process for the preparation of an α-dicarbonyl compound of the cyclopentanopolyhydrophenanthrene series. | |
| CH236175A (en) | Process for the preparation of p-aminobenzenesulfonyl-methyl-thiourea. | |
| DE2120396B2 (en) | Use of l-phenoxy-3-alkoxypropanol- (2) in increasing bile excretion |